


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.35%
+2.15%
+10.74%
-1.92%
MNPR
Monopar Therapeutics
$83.97
Strengths

Upgraded on attractively valued

Outperform the market
Chart
$81.57 (+2.94%)
$30.42 (+176.04%)
$35.78 (+134.68%)
$22.01 (+281.51%)
MNPR has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

High volatilty

MNPR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Outperform the market
![]()
MNPR Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MNPR Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is MNPR current stock price?
What are MNPR stock strengths?
What is MNPR Risk Level?
What is MNPR market cap and volume?
What is MNPR current Stock IQ?
Should I buy MNPR stock right now?
Is MNPR a Strong Buy right now?
What does a 'Strong Buy' rating mean for MNPR?
What does a 'Strong Sell' rating mean for MNPR?
What factors influence MNPR's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.35%
+2.15%
+10.74%
-1.92%
MNPR
Monopar Therapeutics
Current Price
$83.97
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market

Chart
$81.57 (+2.94%)
$30.42 (+176.04%)
$35.78 (+134.68%)
$22.01 (+281.51%)
MNPR Analysts Opinion
MNPR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Outperform the market
![]()
MNPR Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MNPR Street Sentiment is extremely bullish and have positive views on the near-term outlook
MNPR has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

High volatilty

Average key support and resistance price levels.
MNPR Latest Analysis
Chardan Capital Maintains Monopar Therapeutics (MNPR) Buy Recommendation. Fintel reports that on November 13 2025 Chardan Capital maintained coverage of Monopar Therapeutics (NasdaqCM:MNPR) with a Buy recommendation. Analyst Price Forecast Suggests 30.81% Upside
Fri Nov 14, 2025
Monopar Therapeutics GAAP EPS of -$0.48 misses by $0.05.
Fri Nov 14, 2025
Chardan Capital Maintains Monopar Therapeutics (MNPR) Buy Recommendation. Fintel reports that on November 9 2025 Chardan Capital maintained coverage of Monopar Therapeutics (NasdaqCM:MNPR) with a Buy recommendation. Analyst Price Forecast Suggests 38.11% Upside
Tue Nov 11, 2025
Leerink Partners Initiates Coverage of Monopar Therapeutics (MNPR) with Outperform Recommendation. Fintel reports that on November 10 2025 Leerink Partners initiated coverage of Monopar Therapeutics (NasdaqCM:MNPR) with a Outperform recommendation. Analyst Price Forecast Suggests 40.60% Upside
Mon Nov 10, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MNPR Stock trends
MNPR Stock performance
MNPR Stock analysis
MNPR investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.